

Instance: composition-en-d2fbf2f2639d83ae5727c01cf5210fc3
InstanceOf: CompositionUvEpi
Title: "Composition for intuniv Package Leaflet"
Description:  "Composition for intuniv Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - intuniv"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet:
1. What Intuniv is and what it is used for
2. What you need to know before you take Intuniv
3. How to take Intuniv
4. Possible side effects
5. How to store Intuniv
6. Contents of the pack and other information
         </div>"""   
          

* section[=].section[+]
  * title =  "1. What intuniv is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What intuniv is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Intuniv is
Intuniv contains the active substance guanfacine. This medicine belongs to a group of medicines 
which affects brain activity. This medicine can help improve your attention, concentration and make 
you less impulsive and hyperactive.
What Intuniv is used for
This medicine is used to treat  attention deficit hyperactivity disorder  (ADHD) in children and 
adolescents 6-17 years old for whom current stimulant medication is not appropriate and/or current 
medication does not adequately control ADHD symptoms.
The medicine is given as part of a treatment programme, which usually includes the following:</p>
<p>psychological therapy</p>
<p>educational therapy</p>
<p>social therapy
About ADHD
People with ADHD find it hard to:</p>
<p>sit still</p>
<p>concentrate.
ADHD can cause problems with everyday life. Children and young people with ADHD may have 
difficulty learning and doing homework. They can find it hard to behave well at home, at school or in 
other places.</p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take intuniv"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take intuniv"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Intuniv if:</p>
<p>you are allergic to guanfacine or any of the other ingredients of this medicine (listed in 
section 6).
Warnings and precautions
Talk to your doctor or pharmacist before taking this medicine if:</p>
<p>you have low or high blood pressure, heart problems or have a family history of heart problems</p>
<p>you have fainted recently</p>
<p>you have thoughts or feelings of suicide</p>
<p>you suffer from any other psychiatric conditions
Talk to your doctor or pharmacist if you are taking this medicine and:</p>
<p>experience aggressive feelings or behaviour, or</p>
<p>have suicidal thoughts or feelings
Intuniv may affect your weight and height if taking for long periods, your doctor will therefore 
monitor your growth.
Do not stop taking Intuniv without talking to your doctor. If you suddenly stop taking Intuniv, you 
may develop withdrawal symptoms of increased heart rate and high blood pressure (see section 4).
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking 
this medicine. This is because this medicine can make these problems worse. Your doctor will 
routinely monitor you to see how this medicine affects you.
Children (under 6 years old) and adults (18 years and over)
This medicine should not be used in children under 6 years of age and adults 18 years and over
because it is not known if it works or is safe.
Checks your doctor will do when you take Intuniv
Before you start taking this medicine your doctor will check to make sure this medicine is safe for you 
and that it will help you. While you are taking this medicine your doctor will repeat these checks 
weekly during initial dosing, after dose adjustments, at least every 3 months for the first year and then 
at least twice a year. These checks may include:</p>
<p>your blood pressure and heart rate and other checks on your heart if appropriate</p>
<p>your response to treatment, in particular if it makes you sleepy or drowsy</p>
<p>your height and weight
You should talk to your doctor if you do not feel better or if you feel worse and very sleepy or drowsy 
after taking this medicine for around 6 weeks. Your doctor may want to review your treatment
Other medicines and Intuniv
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. This is because Intuniv and some other medicines can affect each other.
In particular, tell your doctor or pharmacist if you are taking any of the following types of medicines:</p>
<p>medicines that lower your blood pressure (antihypertensives)</p>
<p>medicines for epilepsy such as valproic acid</p>
<p>medicines that make you sleepy (sedatives)</p>
<p>medicines for mental health problems (benzodiazepines, barbiturates and antipsychotics)</p>
<p>medicines that can affect the way Intuniv is eliminated by the liver (please see table below)
Medicines
Used to treat
Aprepitant
Nausea and vertigo.
Atazanavir, efavirenz, etravirine, 
fosamprenavir, indinavir, nevirapine, 
ritonavir, saquinavir
HIV infection.
Ciprofloxacin, chloramphenicol, 
clarithromycin, erythromycin, rifabutin, 
rifampicin, telithromycin
Bacterial infections.
Fluconazole, itraconazole, posaconazole, 
ketoconazole
Fungal infections.
Crizotinib, imatinib
Cancer.
Diltiazem, verapamil
Cardiovascular conditions.
Boceprevir, telaprevir
Viral hepatitis.
Suboxone
Substance dependence.
Bosentan
Cardiovascular conditions (e.g. constriction of 
blood vessels in the lung).
Carbamazepine, oxcarbazepine, 
phenobarbital, phenytoin, primidone
Used to control epilepsy.
Modafinil
Is a medicine that promotes alertness and is used to 
treat sleep disorders.
St. John s Wort
Is a herbal preparation that is used to treat 
depression.
If any of the above apply to you or you are not sure, talk to your doctor or pharmacist before taking 
this medicine.
Intuniv with food, drinks and alcohol</p>
<p>Do not take this medicine with fatty foods (e.g., high fat breakfast), as it may affect the way this 
medicine works.</p>
<p>Do not take grapefruit juice with this medicine as it can have an effect on the way this medicine
works.</p>
<p>Do not drink alcohol when taking this medicine as it may make you sleepy or drowsy.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine.</p>
<p>Do not take this medicine if you are pregnant or you are not using contraception. It is not known 
if Intuniv will affect your unborn baby.</p>
<p>Do not breast-feed while taking Intuniv unless told to do so by your doctor.
Driving and using machines
You may feel dizzy and drowsy when taking this medicine, especially at the start of treatment and this 
may last for 2 to 3 weeks possibly longer. If this happens, do not drive, cycle, use any tools or 
machines or participate in activities that could cause injury until you know how this medicine affects 
you. Fainting has also been reported but is not a common effect.
Intuniv contains lactose
Lactose is a type of sugar. If you have been told by your doctor that you have an intolerance to some 
sugars, contact your doctor before taking this medicine.
Intuniv contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially  sodium-
free .</p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take intuniv"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take intuniv"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Your treatment will start under the supervision of an appropriate specialist in childhood and/or 
adolescent behavioural disorders.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure.
As part of your treatment your doctor will closely monitor how Intuniv is affecting you during initial 
dosing and/or dose adjustments.
How much to take</p>
<p>Your doctor will start you on 1 mg per day. Your doctor may increase your dose based on your 
body weight and how Intuniv is working for you but not by more than 1 mg per week.
Depending on how you respond to treatment your doctor may increase your dose more slowly.
The recommended maintenance dose is between 0.05 up to 0.12 mg per kg of bodyweight per 
day.</p>
<p>You may not notice an immediate effect upon starting treatment, some patients may notice an 
improvement after the first week but it could take longer.</p>
<p>Your daily dose will be between 1 and 7 mg depending on your age and how you respond to 
Intuniv, but not more that 7 mg.
How to take Intuniv</p>
<p>This medicine should be taken once a day either in the morning or evening.</p>
<p>It can be taken with or without food, but do not take it with fatty foods (e.g., high fat breakfast).</p>
<p>Swallow the tablet whole with a drink of water or other liquid (but not grapefruit juice).</p>
<p>Do not break, crush or chew the tablet; this will affect how the tablet works. Tell your doctor if 
you cannot swallow the tablet whole.
Duration of treatment
If you need to take Intuniv for more than a year your doctor will monitor your response to treatment
and your doctor may stop the medicine for a short time; this may happen during a school holiday. This 
will show if you still need to take the medicine.
If you take more Intuniv than you should
If you take more Intuniv than you should, talk to a doctor or go to a hospital straight away. Take the 
medicine pack with you and tell them how much you have taken.
The following effects may happen: low or high blood pressure, slow heart rate, slow breathing rate, 
feeling tired or exhausted.
If you forget to take Intuniv
If you forget a dose, wait until the next day and take your usual dose.</p>
<p>If you have missed two or more doses talk to your doctor as you may need to restart Intuniv 
with a lower dose.</p>
<p>Do not take a double dose to make up for a forgotten dose.
If you stop taking Intuniv
Do not stop taking this medicine without first talking to your doctor.</p>
<p>If you stop taking this medicine your blood pressure and heart rate may increase (see section 4 
below).</p>
<p>To stop the medicine, your doctor will slowly reduce your Intuniv dose to minimise any side 
effects.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. If you are 
worried, speak to your doctor.
If you feel unwell in any way while you are taking your medicine please tell an adult straight 
away.
Serious side effects
The following serious side effects have been reported: feeling drowsy (sedation), feeling dizzy 
(hypotension), slow heart beat (bradycardia), feeling faint or loss of conciousness (syncope), a serious 
withdrawal side effect of high blood pressure after suddenly stopping Intuniv; symptoms may include 
headaches, feeling confused, nervousness, agitation, and tremors (hypertensive encephalopathy).
Some of these side effects are more likely to occur at the start of treatment and may disappear as you 
continue with your treatment, if you experience any of these side effects contact your doctor straight 
away.
Other side effects
The following side effects have been reported.
Very common (may affect more than 1 in 10 people)</p>
<p>feeling sleepy (somnolence)</p>
<p>feeling tired (fatigue)</p>
<p>headache</p>
<p>tummy pain (abdominal pain).
Common (may affect up to 1 in 10 people)</p>
<p>low heart rate</p>
<p>blood pressure decreased</p>
<p>feeling restless or irritable</p>
<p>trouble sleeping (insomnia) or broken sleep (middle insomnia) or nightmares</p>
<p>feeling depressed, worried (anxiety) or having mood swings (affect lability)</p>
<p>lack of energy (lethargy)</p>
<p>weight gain</p>
<p>loss of appetite</p>
<p>have a dry mouth</p>
<p>wetting yourself (enuresis)</p>
<p>feeling (nausea) or being sick (vomiting)</p>
<p>diarrhoea, abdominal discomfort or constipation</p>
<p>low blood pressure when standing up (orthostatic hypotension)</p>
<p>rash.
Uncommon (may affect up to 1 in 100 people)</p>
<p>allergic reaction (hypersensitivity)</p>
<p>chest pain</p>
<p>indigestion (dyspepsia)</p>
<p>trouble breathing (asthma)</p>
<p>feeling weak (asthenia)</p>
<p>pale skin colour (pallor)</p>
<p>fits or convulsions</p>
<p>need to urinate frequently (pollakiuria)</p>
<p>feeling agitated</p>
<p>aggression</p>
<p>changes in liver blood test results (increased alanine aminotransferase)</p>
<p>increase in blood pressure</p>
<p>unusual heart rhythm (sinus arrhythmia and first-degree arterioventricular block)</p>
<p>fast heart beat (tachycardia)</p>
<p>reduced heart rate</p>
<p>feeling dizzy when standing up (postural dizziness)</p>
<p>itchy skin (pruritus)</p>
<p>seeing or hearing things that are not there (hallucination).
Rare (may affect up to 1 in 1,000 people)</p>
<p>sleeping more than normal (hypersomnia)</p>
<p>high blood pressure (hypertension)</p>
<p>feeling unwell (malaise).
Very rare (may affect up to 1 in 10,000 people)</p>
<p>a serious withdrawal side effect of high blood pressure after suddenly stopping Intuniv; 
symptoms may include headaches, feeling confused, nervousness, agitation, and tremors 
(hypertensive encephalopathy).
Not known (frequency cannot be estimated from the available data)</p>
<p>difficulty to get or keep an erection (erectile dysfunction).
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine.</p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store intuniv"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store intuniv"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister pack after EXP. 
The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not use this medicine if the tablets or blister pack look damaged.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment.</p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Intuniv contains</p>
<p>Each 1 mg tablet contains guanfacine hydrochloride equivalent to 1 mg of guanfacine</p>
<p>Each 2 mg tablet contains guanfacine hydrochloride equivalent to 2 mg of guanfacine</p>
<p>Each 3 mg tablet contains guanfacine hydrochloride equivalent to 3 mg of guanfacine</p>
<p>Each 4 mg tablet contains guanfacine hydrochloride equivalent to 4 mg of guanfacine</p>
<p>The other ingredients are hypromellose 2208, methacrylic acid-ethyl acrylate copolymer, lactose
monohydrate, povidone, crospovidone Type A, microcrystalline cellulose, silica colloidal 
anhydrous, sodium laurilsulfate, polysorbate 80, fumaric acid, glycerol dibehenate.</p>
<p>The 3 mg and 4 mg tablets also contain indigo carmine aluminium lake (E 132) and yellow iron 
oxide (E 172)
What Intuniv looks like and contents of the pack
Intuniv is a prolonged-release tablet which means that the active substance is released from the tablet 
over a period of time. The tablets come in pack sizes of 7, 28 or 84 but not all pack sizes may be 
available.</p>
<p>The 1 mg prolonged-release tablets are round and white, hard tablets, debossed with 1MG on 
one side and 503 on the other side.</p>
<p>The 2 mg prolonged-release tablets are oval and white, hard tablets, debossed with 2MG on one 
side and 503 on the other side.</p>
<p>The 3 mg prolonged-release tablets are round and green, hard tablets, debossed with 3MG on 
one side and 503 on the other side.</p>
<p>The 4 mg prolonged-release tablets are oval and green, hard tablets, debossed with 4MG on one 
side and 503 on the other side.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 HWIreland
Manufacturer
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 HWIreland
Shire Pharmaceuticals Ireland Limited
Block 2 &amp; 3 Miesian Plaza
50   58 Baggot Street Lower
Dublin 2
Ireland
For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder:
Belgi /Belgique/Belgien
Takeda Belgium NV
T l/Tel: +32 2 464 06 medinfoEMEA@takeda.com
Lietuva
Takeda, UAB
Tel: +370 521 09 medinfoEMEA@takeda.com</p>
<p>.: +359 2 958 27 medinfoEMEA@takeda.com 
Luxembourg/Luxemburg
Takeda Belgium NV
T l/Tel: +32 2 464 06 medinfoEMEA@takeda.com
 esk  republika
Takeda Pharmaceuticals Czech Republic s.r.o.
Tel: +420 234 722 medinfoEMEA@takeda.com
Magyarorsz g
Takeda Pharma Kft.
Tel.: +36 1 270 7medinfoEMEA@takeda.com
Danmark
Takeda Pharma A/S
Tlf: +45 46 77 10 medinfoEMEA@takeda.com
Malta
 akeda HELLAS S.A.
Tel: +30 210 6387medinfoEMEA@takeda.com
Deutschland
Takeda GmbH
Tel: +49 (0)800 825 3medinfoEMEA@takeda.com
Nederland
Takeda Nederland B.V.
Tel: +31 20 203 5medinfoEMEA@takeda.com
Eesti
Takeda Pharma AS
Tel: +372 6177 medinfoEMEA@takeda.com
Norge
Takeda AS
Tlf: +47 800 800 medinfoEMEA@takeda.com</p>
<p>akeda    . .
T : +30 210 6387medinfoEMEA@takeda.com
 sterreich
Takeda Pharma Ges.m.b.H. 
Tel: +43 (0) 800-20 80 medinfoEMEA@takeda.com
Espa a
Takeda Farmac utica Espa a S.A.
Tel: +34 917 90 42 medinfoEMEA@takeda.com
Polska
Takeda Pharma Sp. z o.o.
Tel.: +48223062medinfoEMEA@takeda.com
France
Takeda France SAS
T l: + 33 1 40 67 33 medinfoEMEA@takeda.com
Portugal
Takeda Farmac uticos Portugal, Lda.
Tel: + 351 21 120 1medinfoEMEA@takeda.com
Hrvatska
Takeda Pharmaceuticals Croatia d.o.o.
Tel: +385 1 377 88 medinfoEMEA@takeda.com
Rom nia
Takeda Pharmaceuticals SRL
Tel: +40 21 335 03 medinfoEMEA@takeda.com
Ireland
Takeda Products Ireland Ltd
Tel: 1800 937 medinfoEMEA@takeda.com
Slovenija
Takeda Pharmaceuticals farmacevtska dru ba d.o.o.
Tel: + 386 (0) 59 082 medinfoEMEA@takeda.com
 sland
Vistor hf.
S mi: +354 535 7medinfoEMEA@takeda.com
Slovensk  republika
Takeda Pharmaceuticals Slovakia s.r.o.
Tel: +421 (2) 20 602 medinfoEMEA@takeda.com
Italia
Takeda Italia S.p.A.
Tel: +39 06 502medinfoEMEA@takeda.com
Suomi/Finland
Takeda Oy
Puh/Tel: 0800 774 medinfoEMEA@takeda.com</p>
<p>akeda    . .
 : +30 210 6387medinfoEMEA@takeda.com
Sverige
Takeda Pharma AB
Tel: 020 795 medinfoEMEA@takeda.com
Latvija
Takeda Latvia SIA
Tel: +371 67840medinfoEMEA@takeda.com
United Kingdom (Northern Ireland)
Takeda UK Ltd
Tel: +44 (0) 2830 640 medinfoEMEA@takeda.com
This leaflet was last revised in .
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

